A*Star scholar wins prestigious prize for young life scientists

December 28, 2010

A*STAR scholar, Dr Melissa Fullwood, has become the first Singaporean to win one of four Regional General Electric (GE) & Science Prizes for Young Life Scientists this year for her original essay, "Genome-Wide Chromatin Loops Regulate Transcription". This is a huge honour for the scientist in her 20s as she now ranks among 80 promising young scientists in the field of molecular biology worldwide who have received the Prize since it was first awarded in 1995. Many Prize winners now work in the world's most prestigious labs such as at the University of Tokyo, the University of Liege, Harvard University, and the University of California.

Dr Fullwood's winning essay addresses the unanswered question of why there are so few genes in the genome (which has abundant "non-gene" regions not coding for any specific proteins). It is based on her PhD project at the NUS Graduate School for Integrative Sciences and Engineering and A*STAR's Genome Institute of Singapore (GIS). Then, she was instrumental in developing a new technology to study how DNA interactions affected the development of cancer. Her findings demonstrated that there was a complex network of chromatin interaction between genes and non-coding regions of the genome, and that chromatin interactions could be the cause of genetic deregulations and diseases such as cancer. This major breakthrough in cancer research received funding from the National Institutes of Health in the United States and was published in premier scientific journal Nature.

Said Dr Fullwood, "I'm absolutely delighted to be a Regional Winner of the GE & Science Prize, and to have made a key discovery about the genome that will help many others in genomics research. I hope to continue unravelling the complexities of gene regulation, and to bring about further breakthroughs in our understanding of diseases and how they may be treated."

Dr Fullwood will receive a cash award of US$5,000 and a trip to Stockholm to receive the award on 10 December 2010 at the Grand Hôtel. In addition, her essay will be published on the Science website in December 2010. The GE & Science Prize for Young Life Scientists is an initiative between global healthcare product and service provider GE Healthcare and the highly regarded Science magazine to support and reward promising young scientists in the field of molecular biology.


Dr Fullwood has an impressive list of achievements to her name. She graduated with a Bachelor's in Biological Sciences with Honours from Stanford University in 2005, before going on to pursue her PhD in Genomics at the NUS Graduate School for Integrative Sciences and Engineering and A*STAR's Genome Institute of Singapore (GIS) from 2006 to 2009. Dr Fullwood has also first-authored or co-first-authored six other research papers and reviews, as well as given presentations at several symposiums both overseas and locally.

Said Dr Fullwood's PhD mentor and Associate Director at GIS, Dr Ruan Yijun, "Melissa demonstrated that she has all the ingredients for success during her PhD studies in my group. She worked very hard and had great sense to integrate complicated data and tasks together. I am happy to see that Singapore has proved a very positive environment to nurture young talent like her. I am also glad that her accomplishments are starting to be recognised internationally. Melissa is clearly on track to becoming a star scientist, and we wish her all the best in her scientific career."

Dr Fullwood was also one of three recipients of the inaugural L'Oreal Singapore for Women in Science National Fellowships in August 2009. She was also one of 16 nominees under the Science and Technology category for the Great Women of Our Time Awards 2010, organised by The Singapore Women's Weekly magazine. She is currently a Lee Kuan Yew Post-Doctoral Fellow in the Duke-NUS Graduate Medical School under the A*STAR-Duke-NUS Neuroscience Research Partnership, where her research focuses on using genomic technologies to understand cell death pathways activated by cell stress.

Agency for Science, Technology and Research (A*STAR), Singapore

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.